← Back to Analyst Consensus 
ZVRA Buy
ZEVRA THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 15
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 3, 2026 (7 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 7, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 6, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 48% |
| Jul 27, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jul 27, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jul 27, 2026 | BTIG | maintain | Buy → Buy | — | 52% |
| Jun 23, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Jun 11, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 10, 2026 | Maxim Group | maintain | Buy → Buy | — | 42% |
| Jun 10, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 9, 2026 | BTIG | reiterate | Buy → Buy | — | 52% |
| Jun 9, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Jun 9, 2026 | Citizens | maintain | Market Outperform → Market Outperform | — | 48% |
| Jun 8, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| May 8, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Mar 16, 2026 | BTIG | initiate | — → Buy | $23 | 52% |
| Nov 6, 2025 | Canaccord Genuity | maintain | Buy → Buy | $24 | 48% |
| Nov 6, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $24 | 50% |
| Aug 13, 2025 | JMP Securities | maintain | Market Outperform → Market Outperform | $18 | 53% |
| Jul 10, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $29 | 50% |
| Jul 2, 2025 | HC Wainwright & Co. | initiate | — → Buy | $26 | 44% |
| May 14, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $25 | 50% |
| Mar 13, 2025 | Canaccord Genuity | maintain | Buy → Buy | $25 | 48% |
| Mar 13, 2025 | Guggenheim | maintain | Buy → Buy | $22 | 52% |
| Mar 13, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 12, 2025 | Citizens Capital Markets | maintain | Market Outperform → Market Outperform | $18 | 49% |
| Mar 12, 2025 | Cantor Fitzgerald | reiterate | Overweight → Overweight | $25 | 50% |
| Nov 20, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Nov 14, 2024 | Canaccord Genuity | maintain | Buy → Buy | $23 | 48% |
| Oct 11, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Oct 7, 2024 | Guggenheim | initiate | — → Buy | $20 | 52% |
| Oct 1, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Sep 30, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Sep 24, 2024 | JMP Securities | initiate | — → Market Outperform | $17 | 53% |
| Sep 24, 2024 | Maxim Group | maintain | Buy → Buy | $25 | 42% |
| Sep 24, 2024 | Roth MKM | maintain | Buy → Buy | $21 | 52% |
| Sep 20, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $20 | 44% |
| Sep 18, 2024 | Canaccord Genuity | maintain | Buy → Buy | $22 | 48% |
| Aug 14, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 5, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Aug 5, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $18 | 44% |
| Jul 9, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Apr 3, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Apr 1, 2024 | Cantor Fitzgerald | reiterate | — → Overweight | $0 | 50% |
| Mar 12, 2024 | William Blair | initiate | — → Outperform | $0 | 47% |
| Mar 5, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $15 | 44% |
| Dec 28, 2023 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Oct 6, 2023 | Roth MKM | reiterate | Buy → Buy | $25 | 52% |
| Sep 1, 2023 | Canaccord Genuity | reiterate | Buy → Buy | $20 | 48% |
| Aug 15, 2023 | Canaccord Genuity | maintain | Buy → Buy | $20 | 48% |
Price Target Trend
Mar 26, 2026 Oct 27, 2026
EPS Estimates
0y —
0q —
+1y —
+1q —
Cross-Platform Signals
No cross-platform signals in the last 90 days